Michelle Demos

MD, FRCPC

Investigator, BC Children's Hospital
Clinician, Pediatric Neurology and Neurogenetics, BC Children’s Hospital

Epilepsy is one of the most common serious neurological disorders occurring in childhood. Genetic factors have been shown to play an important role in many epilepsy disorders. My research involves the collaboration of other clinicians and researchers from Neurology and Medical Genetics at BC Children's Hospital. The main focus involves studying the different genetic causes of pediatric epilepsy including familial forms of epilepsy and genomic imbalances associated with epilepsy. This research aims to improve diagnosis and treatment of children with genetic forms of epilepsy. Another focus includes identifying clinical features and genetic causes of rare pediatric neurogenetic disorders.

Academic Affiliations

  • Clinical Assistant Professor, Division of Neurology, Department of Pediatrics, Faculty of Medicine, University of British Columbia
  • Research Theme: Brain, Behaviour & Development
  • Research Group(s): Neurodevelopmental and Neurological Disorders; Rare Diseases

Contact Information

Location

4500 Oak St, Vancouver, BC, Canada, V6H 3N1

The Study of Familial Infantile Seizures in First Nations Children of British Columbia

Swiergala E., Eydoux, P., Connolly M., Farrell K., Field L., Arbour L.
Funding by Sick Kids Foundation/CIHR June 2009 – May 2011 $169,995 + $40,000 salary support and Epilepsy Canada Salary Award (2005-2007) $38,000
A form of familial infantile seizures appears to be affecting First Nations families disproportionately in British Columbia. The seizures affecting the infants of these First Nation families appears to represent a specific form of familial infantile seizures which is likely affecting other First Nations families in B.C. and is due to common genetic factor. This project aims to determine the clinical features of this epilepsy disorder, and identify the genetic cause(s) to provide recommendations for diagnosis and management and improve our understanding of how epilepsy develops.

Genomic Imbalances in Children with Intractable Cryptogenic Epilepsy

Tucker T., Adam S., MacGillivray B, Separovic, Eydoux P., Connolly M, Farrell K, Friedman J.
Supported by BC Clinical Genomics Network.
The cause of epilepsy cannot be identified in more than half of children with seizures. Thirty to 40 per cent of those affected will also have seizures which are intractable to medication. Array Comparative Genomic Hybridization is a relatively new technology being used to identify submicroscopic chromosomal imbalances in patients with mental retardation. It detects imbalances at least twice as frequently as conventional cytogenetic analysis. For this study, we are using array technology to estimate the frequency of genomic imbalances or pathogenic Copy Number Variants in children with intractable unexplained epilepsy and describe their clinical and EEG features. The chromosomal region containing the imbalance will also be examined for candidate epilepsy genes.

Related News

Every day, our researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.

Our Research

At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.

EXPLORE OUR RESEARCH

Stay in the Know

Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.

This field is for validation purposes and should be left unchanged.